EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aging‐Driven Immunosuppression: The Role of Tregs in the Ovarian Tumor Microenvironment

Mary P Udumula, Anjaly Km, Faraz Rashid, Mohammad Nematullah, Harshit Singh, Tanya Bhardwaj, Miriana Hijaz, Shailendra Giri, Eduardo N Chini iD, Heather M Gibson, Ramandeep Rattan

Aging Cell · 2026-05 · 25 (5)

DOI: 10.1111/acel.70510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 24.04.2026. Verfasst von Mary P Udumula und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Henry Ford Hospital, Detroit, Michigan, USA. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Tumor Microenvironment, Aging, Ovarian Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Henry Ford Health System, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epithelial ovarian cancer (EOC) incidence and mortality increase with age, driven in part by chronic inflammation, diminished T cell output, and heightened regulatory T cell (Treg) mediated immunosuppression. In aged EOC‐bearing mice, we observed reduced survival, accompanied by impaired CD4 + and CD8 + T cell responses and a marked expansion of FOXP3 + Tregs exhibiting elevated IL‐10 and TGFβ expression. Metabolic profiling revealed enhanced oxidative phosphorylation in Tregs from aged mice, along with a fivefold increase in intracellular succinate levels. This accumulation of succinate within the aged tumor microenvironment was found to potentiate Treg suppressive function. Notably, pharmacologic inhibition of α‐ketoglutarate dehydrogenase reversed this effect, restoring effector T cell activity. These findings highlight succinate‐driven metabolic reprogramming as a central mechanism of age‐related Treg dysfunction in EOC and suggest that targeting succinate metabolism may offer a promising strategy to rejuvenate antitumor immunity in elderly patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryTumor MicroenvironmentAgingOvarian NeoplasmsImmune ToleranceImmunosuppression TherapyFemaleAnimalsHumansMice

Stichwörter der Autor:innen

Tregsagingimmunosuppression

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Henry Ford Hospital, Detroit, Michigan, USA.
  • Henry Ford Cancer Institute, Detroit, Michigan, USA.
  • Department of Obstetrics, Gynecology & Reproductive Biology, Michigan State University, Lansing, Michigan, USA.
  • Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
  • Department of Biology, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Cancer Biology, Mayo Clinic, Jacksonville, Florida, USA.

ORCID-Profile: Eduardo N Chini

Förderung

  • NCI NIH HHS
  • Henry Ford Health System
  • National Cancer Institute

Zitieren

APA

Udumula, M. P., Km, A., Rashid, F., Nematullah, M., Singh, H., Bhardwaj, T., Hijaz, M., Giri, S., Chini, E. N., Gibson, H. M., & Rattan, R. (2026). Aging‐Driven Immunosuppression: The Role of Tregs in the Ovarian Tumor Microenvironment. Aging Cell, 25(5). https://doi.org/10.1111/acel.70510

Vancouver

Udumula MP, Km A, Rashid F, Nematullah M, Singh H, Bhardwaj T, et al. Aging‐Driven Immunosuppression: The Role of Tregs in the Ovarian Tumor Microenvironment. Aging Cell. 2026;25(5). doi:10.1111/acel.70510

BibTeX
@article{Udumula2026,
  author = {Udumula, Mary P and Km, Anjaly and Rashid, Faraz and Nematullah, Mohammad and Singh, Harshit and Bhardwaj, Tanya and Hijaz, Miriana and Giri, Shailendra and Chini, Eduardo N and Gibson, Heather M and Rattan, Ramandeep},
  title = {Aging‐Driven Immunosuppression: The Role of Tregs in the Ovarian Tumor Microenvironment},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {5},
  doi = {10.1111/acel.70510}
}
Kostenlos starten →